The global artificial intelligence in healthcare market reached USD 7.8 Billion in 2024. Forecasts suggest it will escalate to USD 68.7 Billion by 2033, demonstrating a CAGR of 26.04% during 2025-2033. Growth is driven by rising demand for personalized medicine, remote patient monitoring, and advancements in machine learning techniques for efficient medical image analysis and patient outcome prediction.
Study Assumption Years
- Base Year: 2024
- Historical Years: 2019-2024
- Forecast Period: 2025-2033
Artificial Intelligence in Healthcare Market Key Takeaways
- The market size was USD 7.8 Billion in 2024.
- The market is expected to grow at a CAGR of 26.04% from 2025 to 2033.
- The forecast period for market growth is 2025-2033.
- Increasing AI adoption enhances medical research and drug development processes.
- Growth is driven by the rising volume of digital healthcare data including EHR, medical images, and genomic information.
- Advancements in machine learning enable efficient analysis of medical data, anomaly detection, and improved patient outcome predictions.
- Demand for clinical decision support systems is increasing to aid healthcare professionals with evidence-based recommendations.
- North America leads the market due to advanced technology infrastructure and prevalence of chronic diseases.
Sample Request Link: https://www.imarcgroup.com/artifical-intelligence-healthcare-market/requestsample
Market Growth Factors
The global artificial intelligence in healthcare market is propelled by the increasing demand for AI to improve medical research and drug development. AI technologies streamline drug discovery by analyzing vast data sets, accelerating timelines, and reducing costs. The healthcare industry's rising generation of digital data such as electronic health records (EHRs), medical images, and genomic data provides a fertile ground for AI application, enhancing diagnostics, patient care, and operational efficiencies.
Machine learning advancements play a critical role in efficiently analyzing medical images, detecting anomalies, and helping predict patient outcomes. These algorithms support healthcare professionals by improving diagnostic accuracy and reducing interpretation times. Continuous monitoring enabled by AI applications facilitates real-time alerts to healthcare providers, improving patient prognoses and treatment planning.
The demand for personalized medicine also boosts market growth, with precision medicine tailored to individual genetics and lifestyle. AI systems analyze genetic information en masse to recommend personalized treatment plans, improving outcomes and reducing adverse effects. Furthermore, remote patient monitoring technologies, exemplified by AI-powered wearables like the mCareWatch 241 with SOS buttons and vital sign monitors, increase healthcare accessibility and patient satisfaction, especially in underserved regions.
Market Segmentation
By Offering:
- Hardware
- Software: Dominates the market with AI applications in electronic health record systems, imaging analysis, clinical decision support, and natural language processing tools enhancing digital healthcare.
- Services
By Technology:
- Machine Learning: Holds the largest market share; used for disease diagnosis, prognosis, image interpretation, and predictive analytics.
- Context Aware Computing
- Natural Language Processing
- Others
By Application:
- Robot-Assisted Surgery
- Virtual Nursing Assistant
- Administrative Workflow Assistance
- Fraud Detection
- Dosage Error Reduction
- Clinical Trial Participant Identifier: Largest market share; ensures participant anonymity, data integrity, and security in clinical trials.
- Preliminary Diagnosis
- Others
By End-User:
- Healthcare Providers
- Pharmaceutical and Biotechnology Companies: Largest market share; leverage AI for drug discovery, precision medicine, and targeted therapies.
- Patients
- Others
By Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Regional Insights
North America is the dominant region in the artificial intelligence in healthcare market, owing to its advanced medical infrastructure and high prevalence of chronic disorders among the population. In 2018, 51.8% of adults had at least one chronic condition, and 27.2% had multiple chronic conditions. The presence of cutting-edge computing capabilities, cloud resources, and data storage also supports AI adoption in healthcare.
Recent Developments & News
- September 2024: Salesforce launched AI-enabled healthcare-specific solutions to automate clinician workflows for enhanced patient care quality and efficiency.
- September 2024: Tempus AI, Inc. introduced Olivia, an AI personal health concierge enabling holistic personal health data management.
- September 2024: Harrison.ai revealed Harrison.rad.1, a vision language model tailored for radiology capable of image-related discussions, feature localization, report generation, and reasoning based on clinical context.
Key Players
- Amazon Web Services Inc.
- Cloudmedx Inc.
- DeepMind
- Enlitic Inc.
- General Vision Inc.
- Google Inc.
- International Business Machines
- iCarbonX
- Intel Corporation
- Medtronic
- Micron Technology Inc.
- Microsoft Corporation
- Next It Corporation
- Nuance Communications Inc.
- Nvidia Corporation
- Siemens Healthcare
- Welltok Inc.
Ask for Report Customization:
https://www.imarcgroup.com/request?type=report&id=2079&flag=E
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302